Mohammad Hassan Moshafi Date of Birth
Mohammad Hassan Moshafi Date of Birth
Mohammad Hassan Moshafi Date of Birth
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Abbas Shafiee, Alireza Foroumadi.Synthesis and antibacterial activity <strong>of</strong> nitroaryl thiadiazole–gatifloxacin hybridsEuropean Journal <strong>of</strong> Medicinal Chemistry, 3 October 2008.33- Shafiee A., Haddad Zahmatkesh M., <strong>Mohammad</strong>hosseini N., Khalafy J., EmamiS., <strong>Moshafi</strong>MH., Sorkhi M., Foroumadi A.Synthesis and in-vitro antibacterial activity <strong>of</strong> N-piperazinyl quinolone derivatives with 5-chloro-2- thienyl group .DARU Vol. 16, No. 3 2008 189-195.32- Letafat B, Emami S, Aliabadi A, <strong>Mohammad</strong>hosseini N, <strong>Moshafi</strong> MH, Asadipour A, ShafieeA, Foroumadi A.Synthesis and In-Vitro Antibacterial Activity <strong>of</strong> 5-Substituted 1-Methyl-4-nitro-1Himidazoles.Arch Pharm (Weinheim). 2008 Aug;341(8):497-501.200731- Dehghan Noudeh GH, <strong>Moshafi</strong> M.H, Khazaeli.P,Akef.FStudies on bioemulsifier production by bacillus licheniformis PTCC 1595American journal <strong>of</strong> pharmacology and toxicology 2(4):164-169,200730- Dehghan G.<strong>Moshafi</strong> M.H.,sharififar F, Masoumi M A.Studies on biosurfactant production by Acinetobacter calcoaceticus (PTCC 1318) .Jundishapur j. <strong>of</strong> Natural pharmaceutical .products 2007,2(2):116-123.29- Dehghan G, <strong>Moshafi</strong> MH , Khhazaeli P, Akef F.Properties <strong>of</strong> production and surface activity <strong>of</strong> biosurfactant frombacillus Licheniformi .Razi Drug Information journal ,Winter ,2007, No 12 (39-4228- Pardakhty A, <strong>Moshafi</strong> M.H, Moteshafi H .5
Preparation <strong>of</strong> niosomes containing chloramphenicol sodium succinate and evaluation <strong>of</strong>their physicochemical and antimicrobial properties.J. faculty <strong>of</strong> pharmacy, Tabriz , 2007,Spring, No 1 (11-21)27- Moallem SA, Ahmadi A, <strong>Moshafi</strong> MH, Taghavi MM.Evaluation <strong>of</strong> fetal toxicity <strong>of</strong> HESA-A, a Natural anticancer agent in mice.J. Kerman University <strong>of</strong> Medical Sciences 2007: vol 14,NO 2 (124-133)26- M.H. <strong>Moshafi</strong>, S.H. Mansouri,F. Sharififar and M. Khoshnoodi.Antibacterial and antioxidant activities <strong>of</strong> the essential oil and methanol extract <strong>of</strong> Zatariamultiflora Boiss.J. Kerman University <strong>of</strong> Medical Sciences. 2007: vol 14,NO 1 (33-43)25- Foroumadi A., Sakhteman A., Sharifzadeh Z., <strong>Mohammad</strong>hosseini N.,Hemmateenejad B.,<strong>Moshafi</strong> MH., Vosooghi M., Amini M., Shafiee A. Synthesis, antituberculosis activity andQSAR Study <strong>of</strong> some novel 2- (nitroaryl)-5-(nitrobenzylsulfinyl and sulfonyl)-1,3,4-thiadiazole derivatives DARU, 2007Vol.15,No.4,24- Foroumadi A., Firoozpour l., Nematollahi N.,Ebrahimabadi A.,<strong>Moshafi</strong> M.HSynthesis <strong>of</strong> new Fluoroquinolones containing a N-[5-(Fluorobenzylthio)-1,3,4- thiadiazol-2-yl] piperazine moiety.Asian Journal <strong>of</strong> Chemistry Vol. 19,No. 6 (2007),4547-455223- F. Sharififar, M.H. <strong>Moshafi</strong>, S.H. Mansouri, M. Khodashenas and M. KhoshnoodiIn vitro evaluation <strong>of</strong> antibacterial and antioxidant activities <strong>of</strong> the essential oil andmethanol extract <strong>of</strong> endemic Zataria multiflora Boiss .Food Control,18(2007) 800-805.200622- Dehghan GR. <strong>Moshafi</strong> MH., Torkzadeh S.6
16- Foroumadi A, Soltani F, Jabini R, <strong>Moshafi</strong> MH, Rasnani FM.Antituberculosis agents X. Synthesis and evaluation <strong>of</strong> in vitro antituberculosis activity <strong>of</strong> 2-(5-nitro-2-furyl)- and 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,3,4-thiadiazole derivatives.Arch Pharm Res. 2004 May;27(5):502-6.15- <strong>Moshafi</strong> M.H, Mehrabani M .Antibacterial Activity Studies <strong>of</strong> Salvia Mirzayanii and SalviaAtropatana against Six Standard Gram Positive AND Negative Bacteria.J. Kerman University <strong>of</strong> Medical Sciences 2004; 11 (109-118)200314- Foroumadi A, Ashraf-Askari R, <strong>Moshafi</strong> MH, Emami S, Zeynali A.Synthesis and in vitro antibacterial activity <strong>of</strong> N-[5-(5-nitro-2-furyl)-1,3,4-thiadiazole-2-yl]piperazinyl quinolone derivativesPharmazie. 2003 Jun;58(6):432-3.13- Foroumadi A, Soltani F, <strong>Moshafi</strong> MH, Ashraf-Askari R. Synthesis and in vitro antibacterialactivity <strong>of</strong> some N-(5-aryl-1,3,4-thiadiazole-2-yl)piperazinyl quinolone derivatives.Farmaco. 2003 Oct;58(10):1023-8.12- Foroumadi A, Soltani F, Rezaee MA, <strong>Moshafi</strong> MH.Synthesis and evaluation <strong>of</strong> in vitro antimycobacterial activity <strong>of</strong> some 5-(5-nitro-2-thienyl)-2-(piperazinyl, piperidinyl and morpholinyl)-1,3,4-thiadiazole derivatives.Boll Chim Farm. 2003 Nov;142(9):416-9.11- Khazaeli P, <strong>Moshafi</strong> M.H,…Toothpaste Formulation from Miswak Powder Extract.J. Kerman University <strong>of</strong> Medical Sciences 2003; 10 (46-52).10-<strong>Moshafi</strong> M.H, Mansouri Sh…Identification <strong>of</strong> Beta-Lactamase-Negative-AmpicillinResistance Strains <strong>of</strong> Escherichia coli in 150 Isolates from Urinary Tract Infection andFecal Flora in Kerman. J. Kerman University <strong>of</strong> Medical Sciences 2003; 10(246-250)8
20029- Foroumadi A, Soltani F, <strong>Moshafi</strong> MH.Antituberculosis agents. VI. Activity <strong>of</strong> a new cipr<strong>of</strong>loxacin derivative against Mycobacteriumavium and some drug-resistant strains <strong>of</strong> Mycobacterium tuberculosis.Boll Chim Farm. 2002 Sep- Oct;141(5):394-6.8- <strong>Moshafi</strong>, M.H , Foromadi A,…Evaluation <strong>of</strong> Antibacterial Activity <strong>of</strong> New N-piperazinyl Quinolone Derivatives With 1,3,4-Thiadiazole Group.J. Kerman University <strong>of</strong> Medical Sciences 2002; 9 (32-37).7- Sepehri GH, <strong>Moshafi</strong> M.H,…The Epidemiology and Treatment Response <strong>of</strong> Tuberculosis inthe City <strong>of</strong> Kerman from1366-1376.J. Kerman University <strong>of</strong> Medical Sciences & Health Services Razi Faculty <strong>of</strong> Nursing & Midwifery. 2002; 2 (1-10)20016- Foroumadi A., Davood A., Mirzaei M., Emami S., <strong>Moshafi</strong> M.Synthesis and antibacterial activity <strong>of</strong> some novel N-substituted piperazinyl-quinolones.Boll. Chim. Farm. 140(2001) 411-4165- <strong>Moshafi</strong> M.H & Haghaniat M .The Comparision <strong>of</strong> Bacterial Contamination in Eye Drops Used in Hospitals&PrivatePhysician Centers .Iranian Journal <strong>of</strong> Basic Medical Sciences 2001; 4 (165-169).9
19994- Foroumadi. A. <strong>Moshafi</strong>. M.H., …Synthesis and In-Vitro antibacterial activity <strong>of</strong> new N-substituted piperazinyl quinolones.Pharm.Pharmacol. Commun.1999; (591-594).19983- A.Foroumadi, P.Haghighat, S.Emami and MH.<strong>Moshafi</strong>Synthesis <strong>of</strong> New Piperazinyl Quinolones and Investigation <strong>of</strong> their in vitroAntibacterial Activities.Journal <strong>of</strong> Kerman Medical University <strong>of</strong> Medical Sciences, 1998; 5(3): 103-10919972- Foroumadi A., Emami A., Davood A., <strong>Moshafi</strong> M., Sharifian A., Tabatabaie M.,TarhimifarimaniH., Sepehri G., Shafiee ASynthesis And In-Vitro antibacterial activity <strong>of</strong> N-substituted piperazinyl quinolones.J.Pharm.Sci. 1997; 86(559-563).19941-Rashed T, <strong>Moshafi</strong> M.H,….The Prevalence <strong>of</strong> Campylobacter Jejuni Induced Ggastroenteritis in Patients with DiarrhoeaReferring to Emam Reza Hospital in Mashad, IranJ. Kerman University <strong>of</strong> Medical Sciences 1994; 1 (114-118).10
18- 157 th meeting <strong>of</strong> society for general microbiologySimultaneous resistance <strong>of</strong> Escherichia coli isolated from clinical samples to heavy metalsand antibiotics in Kerman, Iran12-14 sep 2005, keele university Newcastle- England17- 17 th Iranian Congress <strong>of</strong> physiology & PharmacologyStudy <strong>of</strong> inhibitory effect <strong>of</strong> various concentrations <strong>of</strong> Povidone Iodine and cetrimide-Cagainst resistance and susceptible Entrococci to vancomycin and E-coliMH, Mansouri SH and Nojumi F1-4 October 2005 Kerman Iran16- 6 th Iranian congress <strong>of</strong> microbiologystudy <strong>of</strong> bacterial contamination in peripheral vascular catheters used in Shafa hospitalM.H. <strong>Moshafi</strong> , F. Farhangnejad16-18 feb. 2004 Tehran Iran15- 2 nd International Meeting on Medical and Pharmaceutical Chemistry (IMMPC-2)Antibacterial Activity <strong>of</strong> Some Quinolone Derivatives<strong>Moshafi</strong> M.H., Foroumadi A.October, 2004 Antalya- Turkey14-3 rd International Congress <strong>of</strong> Health, Enviroment & natural Productstudy <strong>of</strong> antimicrobal activity <strong>of</strong> verbascum thapsus by bioautographic methodM.H. <strong>Moshafi</strong> M. Mehrabani H.Zolhasab25-28 Sep. 2004 Mashad – IRAN13- 16 th Iranian congress <strong>of</strong> physiology & pharmacologyantibacterial activity <strong>of</strong> herbal extract <strong>of</strong> hedera helix,anthemis rhodocentra, eryngiumcoeruleum , equisetum arvens, and mentha pulegium on 7 microbal sepciesM.H. <strong>Moshafi</strong> , G.R. Sepehrimay 9-13 2003 tarbiat modares university tehran Iran12- 16 th Iranian congress <strong>of</strong> physiology & pharmacologyStudy <strong>of</strong> antibacterial activity <strong>of</strong> leaves <strong>of</strong> phoenix doctylifera ,tamarix florida & morous albaM.H. <strong>Moshafi</strong>may 9-13 2003 tarbiat modares university tehran Iran11-5 th Iranian congress <strong>of</strong> microbiologyThe study <strong>of</strong> incidence <strong>of</strong> urinary tract infections in patients,which reffered to kerman medicallabsM.H. <strong>Moshafi</strong>Jan. 21-23, 2003 Ahwaz Iran13
Current Research Project:- Determination <strong>of</strong> Co-Amoxiclav MIC (Minimum Inhibitory Concentration) Against HospitalStrains <strong>of</strong> Staphylococus Aureus & Staphylococus Epidermis.- Synthesis and evaluation <strong>of</strong> antibacterial activity <strong>of</strong> new N- piperazinyl quinolone derivatives.-Synthesis and evaluation <strong>of</strong> the antibacterial activity <strong>of</strong> 15 novel gatifloxacin derivativesagainst ten standard strains <strong>of</strong> bacteria.- Synthesis and evaluation <strong>of</strong> in vitro anti-helicobacter pylori activity <strong>of</strong> [5-(5-nitro-2-furyl)-1,3,4-thiadiazole-2-yl] piperazine derivatives.E-mail<strong>Moshafi</strong>14@yahoo.com15
Change language